- Home
- LVRO vs ENGN Comparison
LVRO vs ENGN Comparison
Compare LVRO & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- ENGN
- Stock Information
- Founded
- LVRO 2017
- ENGN 1999
- Country
- LVRO Brazil
- ENGN Canada
- Employees
- LVRO N/A
- ENGN N/A
- Industry
- LVRO Blank Checks
- ENGN
- Sector
- LVRO Finance
- ENGN
- Exchange
- LVRO Nasdaq
- ENGN Nasdaq
- Market Cap
- LVRO 387.1M
- ENGN 317.6M
- IPO Year
- LVRO N/A
- ENGN N/A
- Fundamental
- Price
- LVRO $3.25
- ENGN $6.97
- Analyst Decision
- LVRO Strong Buy
- ENGN Strong Buy
- Analyst Count
- LVRO 3
- ENGN 9
- Target Price
- LVRO $6.83
- ENGN $29.78
- AVG Volume (30 Days)
- LVRO 14.3K
- ENGN 108.9K
- Earning Date
- LVRO 03-06-2025
- ENGN 03-10-2025
- Dividend Yield
- LVRO N/A
- ENGN N/A
- EPS Growth
- LVRO N/A
- ENGN N/A
- EPS
- LVRO N/A
- ENGN N/A
- Revenue
- LVRO $1,691,812,087.00
- ENGN N/A
- Revenue This Year
- LVRO N/A
- ENGN N/A
- Revenue Next Year
- LVRO $12.53
- ENGN N/A
- P/E Ratio
- LVRO N/A
- ENGN N/A
- Revenue Growth
- LVRO 0.48
- ENGN N/A
- 52 Week Low
- LVRO $3.06
- ENGN $4.42
- 52 Week High
- LVRO $8.33
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- LVRO 27.62
- ENGN 46.21
- Support Level
- LVRO $3.06
- ENGN $6.32
- Resistance Level
- LVRO $3.97
- ENGN $8.40
- Average True Range (ATR)
- LVRO 0.44
- ENGN 1.03
- MACD
- LVRO -0.16
- ENGN 0.01
- Stochastic Oscillator
- LVRO 7.48
- ENGN 37.71
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.